[{"Assets_0_Q3_USD":327383000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":10645000.0,"NetIncomeLoss_1_Q3_USD":47043000.0,"NetIncomeLoss_3_Q3_USD":50606000.0,"EarningsPerShareBasic_1_Q3_USD":0.67,"EarningsPerShareBasic_3_Q3_USD":0.73,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":69877693.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":69501835.0,"Ticker":"CHRS","CIK":"1512762","name":"COHERUS BIOSCIENCES, INC.","OfficialName":"Coherus BioSciences Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"802681020.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191108"}]